Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database
Tsubasa Takizawa(Keio University), Masahiro Iijima(Shinshu University), Kanae Togo(Pfizer (Japan)), Takahiro Kitano(Pfizer (Japan)), Reiko Yoshikawa(Pfizer (Japan))
Cited by 4
Related Papers
Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy
|Neurology|2004|224
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|174
Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population
|Journal of Neurology Neurosurgery & Psychiatry|2008|114
Spreading depolarizations trigger caveolin‐1–dependent endothelial transcytosis
|Annals of Neurology|2018|107